Publicaciones en colaboración con investigadores/as de University of Bordeaux (16)

2023

  1. Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer (Molecular Cancer, (2023), 22, 1, (86), 10.1186/s12943-023-01788-w)

    Molecular Cancer

  2. The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer

    Molecular Cancer, Vol. 22, Núm. 1

2021

  1. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation

    Nature Genetics, Vol. 53, Núm. 9, pp. 1311-1321

2018

  1. N-terminal acetylation modulates Bax targeting to mitochondria

    International Journal of Biochemistry and Cell Biology, Vol. 95, pp. 35-42

  2. The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia

    Neurobiology of Disease, Vol. 118, pp. 64-75

2014

  1. Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice

    EMBO Molecular Medicine, Vol. 6, Núm. 10, pp. 1246-1262

2004

  1. How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)

    Trends in Neurosciences

2001

  1. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria

    Molecular Therapy, Vol. 3, Núm. 3, pp. 411-417

  2. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection

    Molecular Therapy, Vol. 4, Núm. 4, pp. 331-338

  3. Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 8, Núm. 1, pp. 41-47

  4. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells

    Gene Therapy, Vol. 8, Núm. 8, pp. 618-626

2000

  1. Reversion of hepatobiliary alterations by bone marrow transplantation in a murine model of erythropoietic protoporphyria

    Hepatology, Vol. 32, Núm. 1, pp. 73-81

1999

  1. A novel immunodeficient mouse model - RAG2 x common cytokine receptor γ chain double mutants - Requiring exogenous cytokine administration for human hematopoietic stem cell engraftment

    Journal of Interferon and Cytokine Research, Vol. 19, Núm. 5, pp. 533-541

  2. Fluorescence-based Selection of Retrovirally Transduced Cells in Congenital Erythropoietic Porphyria: Direct Selection Based on the Expression of the Therapeutic Gene

    Journal of Gene Medicine, Vol. 1, Núm. 5, pp. 322-330

  3. Perspectives de therapie genique en hematologie

    Annales de Biologie Clinique, Vol. 57, Núm. 1, pp. 43-50

1998

  1. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection

    Hepatology, Vol. 27, Núm. 2, pp. 584-589